AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 237 filers reported holding AXSOME THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.57 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2023 | $6,593,634 | -9.5% | 82,845 | -20.5% | 0.21% | -16.1% |
Q3 2023 | $7,281,839 | -15.0% | 104,190 | -12.6% | 0.25% | -12.6% |
Q2 2023 | $8,566,431 | +16.5% | 119,210 | 0.0% | 0.28% | +8.4% |
Q1 2023 | $7,352,873 | -74.2% | 119,210 | -67.8% | 0.26% | -74.3% |
Q4 2022 | $28,539,643 | +1196.1% | 370,020 | +649.9% | 1.02% | +1120.2% |
Q3 2022 | $2,202,000 | +857.4% | 49,340 | +722.3% | 0.08% | +950.0% |
Q2 2022 | $230,000 | – | 6,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ALETHEA CAPITAL MANAGEMENT, LLC | 788,263 | $35,172,000 | 44.43% |
Fairmount Funds Management LLC | 1,896,647 | $84,628,000 | 14.88% |
ACT CAPITAL MANAGEMENT, LLC | 73,000 | $3,257,000 | 4.50% |
Ghost Tree Capital, LLC | 300,000 | $13,386,000 | 3.76% |
Ikarian Capital, LLC | 407,600 | $18,188,000 | 3.62% |
Paradigm Biocapital Advisors LP | 520,080 | $23,206,000 | 3.09% |
MORGAN JESS S & CO INC | 78,895 | $3,520,000 | 3.06% |
PFM Health Sciences, LP | 1,659,733 | $74,057,000 | 2.68% |
RTW INVESTMENTS, LP | 1,882,164 | $83,982,000 | 1.94% |
Ghost Tree Capital, LLC | 150,000 | $6,693,000 | 1.88% |